Nicotine replacement plus a smartphone quit-smoking app for Hispanic adults
Providing nicotine replacement therapy to enhance the efficacy of a smoking cessation smartphone app for Hispanic adults
This project tests whether giving nicotine replacement therapy together with a smartphone quit-smoking app helps Hispanic adults stop smoking.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11264862 on NIH RePORTER |
What this research studies
You would join if you are a Hispanic adult who smokes and uses a smartphone. Participants are enrolled to use a proven quit-smoking app and some will also be given nicotine replacement therapy to use alongside the app. The project follows participants over time to compare quitting rates between people who get the app alone and those who get the app plus nicotine replacement. Most activities can be done through the app and follow-up contact, making participation possible without frequent clinic visits.
Who could benefit from this research
Good fit: Ideal candidates are Hispanic adults age 21 or older who currently smoke, want to quit, and have an Android smartphone for using the quit-smoking app.
Not a fit: People without a smartphone, those unwilling to use nicotine replacement, or those already receiving comprehensive cessation services may not gain extra benefit from this project.
Why it matters
Potential benefit: If successful, this approach could make effective quitting support and nicotine replacement more accessible to Hispanic adults and raise long-term quit rates.
How similar studies have performed: Previous trials have shown the iCanQuit app can help people quit and combining behavioral programs with nicotine replacement typically improves quit rates, so this builds on promising prior results.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Bricker, Jonathan B — Fred Hutchinson Cancer Center
- Study coordinator: Bricker, Jonathan B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.